503 / 1084
How to Control the Primary Tumor
in Metastatic Disease
Prospective randomised study (AUS, NZL, CAN & UK)
R
A
Palliative RT: 35 Gy, 15 fr (Can und UK) or
30 Gy, 10 fr (AUS, NZL)
N=220
(151 AC)
Penniment MG et al.
ASCO-GI
2015; abstract 06
N
D
O
M
Same RT;
concomitant Cisplatin and 5FU (d1-4)
Advanced
(mostly
metastatic)
disease
Primary endpoint: improvement of dysphagia (>1 pt on Mellow scale)